Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Heat Shock Protein Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
luminespib
(AUY922) / Ligand
RNS60
/ Revalesio
onalespib
(AT13387) / Otsuka
SNX-5422
/ Esanex
IMR-261
/ Imara, Inc
apatorsen
(OGX-427) / Achieve Life Sciences
ND-L02-s0201
/ Nitto Denko, BMS
minnelide
/ Minneamrita Therap
icapamespib
(PU-AD) / Samus Therap
viagenpumatucel-L
(HS-110) / NightHawk Biosci
RGRN-305
/ Regranion, MC2 Therap
AZX 100
/ Capstone
BOLD-100
/ Bold Therap
KW 2478
/ Kyowa Kirin
carbon monoxide
(HBI-002) / Hillhurst Biopharma
cemdomespib
(RTA 901) / Biogen
locnartecan
(PEN-866) / Tarveda Therap, National Cancer Institute - Bethesda
brivudine
(RP 101) / RESprotect, RedHill, SciClone
